T-CURX GmbH
PrivateLast Round
Series A
Dec 17, 2025
Total Funding Raised
$20.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
T-CURX GmbH is a biotechnology company that develops and commercializes next-generation CAR-T cell therapies for cancer using proprietary non-viral, transposon-based gene transfer technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-CURX GmbH Comparables
Compare T-CURX GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A-SEEDS Co., Ltd. | 83% | |
| Integra Therapeutics | 81% | |
| Carla BioTherapeutics | 79% |
T-CURX GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 17, 2025 | ||||
| Grant | Dec 15, 2020 | ||||
| Grant | Jan 2, 2018 |
Key People
Founding team and executive leadership
T-CURX GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series A |
| BioMedPartners | Series A |
| Highlight Capital | Series A |
| Innovative Health Initiative | Grant |
| European Commission | Grant |
| Bayern Kapital | Series A |
| Bavarian State Ministry of Economic Affairs, Regional Development and Energy | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 117% MoM.
- Jul 29, 2026
Monthly visitors increased 830% MoM, from 115 to 1.1K.
T-CURX GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about T-CURX GmbH's valuation, stock price, and market status.
Is T-CURX GmbH a public or private company?
T-CURX GmbH is a private company.
What is the current stock price of T-CURX GmbH?
T-CURX GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is T-CURX GmbH worth (valuation)?
Valuation information for T-CURX GmbH is not publicly available.
Can I buy T-CURX GmbH stock?
T-CURX GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was T-CURX GmbH's last funding round?
T-CURX GmbH's most recent funding round was Series A on December 18, 2025.
Who are the main investors in T-CURX GmbH?
Key investors in T-CURX GmbH include HighLight Capital, Highlight Capital, European Commission, Bayern Kapital, WuXi Biologics Healthcare Ventures.
Will T-CURX GmbH IPO soon?
No public IPO plans have been announced for T-CURX GmbH.
How can I track T-CURX GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor T-CURX GmbH's secondary market activity and sign up for updates.